Ro 106-9920Cat. No. 1778 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Chemical Name: 6-(Phenylsulfinyl)tetrazolo[1,5-b]pyridazine |
Biological Activity
Inhibitor of NF-κB activation, possibly via selective inhibition of LPS- and TNF-α-induced IκBα ubiquitination (IC50 = 3 μM). Blocks subsequent production of TNF-α, IL-1β and IL-6. Inhibits mucin production in an in vitro model of COPD, and is anti-inflammatory following oral administration in vivo. Also weakly inhibits EGFR, 5-lipoxygenase and iNOS.Certificate of Analysis / Safety Data Sheet
References
Conalty et al (1976) Anticancer agents. XII. Pyridazine and benzodiazine derivatives. Proc.R.Ir.Acad.B. 76 151. PMID: 967871.
Baginski et al (2002) Glucocorticoid modulation of MUC5AC secretion in H292 cells. Am.Soc.Cell Biol.Abstr. 765.
Swinney et al (2002) A small molecule ubiquitination inhibitor blocks NF-κB-dependent cytokine expression in cells and rats. J.Biol.Chem. 277 23573. PMID: 11950839.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: Ro 106-9920, supplier, inhibitors, NF-κB, NF-kappaB, NF-kB, activation, Transcription, Factors, Nuclear, Factor, Kappa, B, Ro106-9920
Quick Order
Find multiple products by catalog number
New Products in this Area
Selectively inhibits PKC-induced NF-κB activation
Tocris Events
Win a Kindle
June 15 - 18, 2013
San Francisco, CA
Booth Number: 1032






